Your Health, We Care
Sotorasib is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.
from FDA，2023.04
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA···【more】
Release date：2026-03-23Recommended：147
On January 17, 2025, Amgen announced that the U.S. Food and Drug Administration ···【more】
Release date：2026-03-23Recommended：168
Sotorasib, also known as AMG-510, is an orally bioavailable drug that falls unde···【more】
Release date：2024-08-05Recommended：366
Sotorasib, a novel small molecule targeted therapeutic agent, presents a promisi···【more】
Release date：2024-08-05Recommended：438
Sotorasib, also known as AMG-510, is an orally bioavailable drug that falls unde···【more】
Release date：2024-07-09Recommended：482
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
